Mubadala invests in global biosimulation leader certara

Princeton, n.j., july 27, 2021 (globe newswire) -- certara (nasdaq: cert), a global leader in biosimulation, today announced that mubadala investment company (mubadala) has made an approximately $250 million investment in certara. the investment aligns with mubadala's strategy of enabling innovation to address unmet clinical needs and drive cost efficiencies.
CERT Ratings Summary
CERT Quant Ranking